BioAge Labs, Inc. (BIOA)
10.11
+0.73
(+7.78%)
USD |
NASDAQ |
Aug 25, 16:00
10.12
0.00 (0.00%)
After-Hours: 19:59
BioAge Labs Market Cap : 462.80M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 462.80M |
| August 24, 2026 | 429.39M |
| August 21, 2026 | 433.96M |
| August 20, 2026 | 443.58M |
| August 19, 2026 | 492.10M |
| August 18, 2026 | 478.83M |
| August 17, 2026 | 476.08M |
| August 14, 2026 | 485.24M |
| August 13, 2026 | 477.45M |
| August 12, 2026 | 479.74M |
| August 11, 2026 | 488.44M |
| August 10, 2026 | 524.15M |
| August 07, 2026 | 536.51M |
| August 06, 2026 | 515.91M |
| August 05, 2026 | 502.63M |
| August 04, 2026 | 512.70M |
| August 03, 2026 | 493.48M |
| July 31, 2026 | 401.26M |
| July 30, 2026 | 1.103B |
| July 29, 2026 | 984.94M |
| July 28, 2026 | 972.96M |
| July 27, 2026 | 926.80M |
| July 24, 2026 | 966.30M |
| July 23, 2026 | 972.07M |
| July 22, 2026 | 973.85M |
| Date | Value |
|---|---|
| July 21, 2026 | 1.005B |
| July 20, 2026 | 990.71M |
| July 17, 2026 | 1.012B |
| July 16, 2026 | 983.61M |
| July 15, 2026 | 1.008B |
| July 14, 2026 | 1.011B |
| July 13, 2026 | 966.97M |
| July 10, 2026 | 1.080B |
| July 09, 2026 | 1.105B |
| July 08, 2026 | 1.049B |
| July 07, 2026 | 1.083B |
| July 06, 2026 | 1.103B |
| July 02, 2026 | 1.114B |
| July 01, 2026 | 1.077B |
| June 30, 2026 | 1.088B |
| June 29, 2026 | 1.107B |
| June 26, 2026 | 1.055B |
| June 25, 2026 | 1.004B |
| June 24, 2026 | 1.013B |
| June 23, 2026 | 990.71M |
| June 22, 2026 | 952.98M |
| June 18, 2026 | 921.91M |
| June 17, 2026 | 887.29M |
| June 16, 2026 | 909.49M |
| June 15, 2026 | 880.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.161T |
| Pfizer Inc. | 162.82B |
| Oramed Pharmaceuticals, Inc. | 215.25M |
| Liquidia Corp. | 6.281B |
| Neumora Therapeutics, Inc. | 280.28M |
Market Cap Related Metrics
| PS Ratio | 38.88 |
| PEG Ratio | -0.6276 |
| Price to Book Value | 1.234 |
| Price | 10.11 |
| Earnings Yield | -23.61% |
| PEGY Ratio | -0.6276 |